Loading...
XNASDXR
Market cap37mUSD
Jan 06, Last price  
7.80USD
1D
2.85%
1Q
-9.79%
Jan 2017
-5.76%
Name

Daxor Corp

Chart & Performance

D1W1MN
XNAS:DXR chart
P/E
134.44
P/S
29.46
EPS
0.06
Div Yield, %
0.00%
Shrs. gr., 5y
4.36%
Rev. gr., 5y
-14.37%
Revenues
1m
-79.71%
1,218,4061,343,5381,486,4491,869,7791,761,0551,688,8261,579,2571,277,422-2,102,214-11,557,630-4,053,710-7,443,8551,835,331-1,011,589-918,449-114,992-996,2995,821,1836,310,2941,280,515
Net income
281k
-94.58%
-580,268-1,335,981-785,53110,647,21615,123,2695,822,7584,968,264-7,185,6391,186,968-8,218,373-976,703-9,146,3501,455,763-1,239,890-885,775-495,697-1,705,3914,748,1975,178,133280,640
CFO
-4m
L+375.12%
-1,830,381-1,156,354-3,440,262-3,143,025-4,039,425-5,253,123-5,690,083-6,508,6484,479,381-9,042,663-295,63618,525,6141,592,691-1,172,515-1,315,6103,112,062-2,447,640-2,758,954-769,298-3,655,068
Dividend
Jan 05, 20180.03 USD/sh

Profile

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
URL
https://www.daxor.com/
IPO date
Jul 25, 1983
Employees
37
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,281
-79.71%
6,310
8.40%
Cost of revenue
1,424
2,173
Unusual Expense (Income)
NOPBT
(144)
4,138
NOPBT Margin
65.57%
Operating Taxes
(860)
Tax Rate
NOPAT
(144)
4,997
Net income
281
-94.58%
5,178
9.05%
Dividends
Dividend yield
Proceeds from repurchase of equity
4,530
1,852
BB yield
-10.19%
-4.95%
Debt
Debt current
Long-term debt
756
1,229
Deferred revenue
Other long-term liabilities
(1,229)
Net debt
(34,088)
(28,994)
Cash flow
Cash from operating activities
(3,655)
(769)
CAPEX
Cash from investing activities
2,746
2,690
Cash from financing activities
3,655
59
FCF
(232)
5,060
Balance
Cash
Long term investments
34,843
30,223
Excess cash
34,779
29,908
Stockholders' equity
25,146
49,626
Invested Capital
9,723
291
ROIC
790.63%
ROCE
13.70%
EV
Common stock shares outstanding
4,631
4,084
Price
9.60
4.80%
9.16
-18.83%
Market cap
44,460
18.85%
37,409
-17.88%
EV
10,372
8,415
EBITDA
(144)
4,138
EV/EBITDA
2.03
Interest
49
72
Interest/NOPBT
1.75%